In This Article:
As of January 2025, the U.S. stock market is experiencing a surge, with major indices like the S&P 500 reaching record highs amid strong corporate earnings and optimism about AI-related developments. Penny stocks may be an old term, but they continue to offer intriguing opportunities for investors seeking growth at lower price points. Typically representing smaller or newer companies, these stocks can present significant upside potential when backed by strong financials and solid fundamentals.
Top 10 Penny Stocks In The United States
| Name | Share Price | Market Cap | Financial Health Rating |
| QuantaSing Group (NasdaqGM:QSG) | $3.08 | $111.94M | ★★★★★★ |
| BAB (OTCPK:BABB) | $0.93 | $6.36M | ★★★★★★ |
| Kiora Pharmaceuticals (NasdaqCM:KPRX) | $3.80 | $11.61M | ★★★★★★ |
| Inter & Co (NasdaqGS:INTR) | $4.94 | $2.18B | ★★★★☆☆ |
| ZTEST Electronics (OTCPK:ZTST.F) | $0.2899 | $10.66M | ★★★★★★ |
| Imperial Petroleum (NasdaqCM:IMPP) | $2.90 | $88.72M | ★★★★★★ |
| Golden Growers Cooperative (OTCPK:GGRO.U) | $4.50 | $67.38M | ★★★★★★ |
| BTCS (NasdaqCM:BTCS) | $3.38 | $54.13M | ★★★★★★ |
| Smith Micro Software (NasdaqCM:SMSI) | $1.26 | $22.7M | ★★★★★☆ |
| CBAK Energy Technology (NasdaqCM:CBAT) | $0.92 | $83.39M | ★★★★★☆ |
Click here to see the full list of 706 stocks from our US Penny Stocks screener.
Here's a peek at a few of the choices from the screener.
111
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: 111, Inc., along with its subsidiaries, operates an integrated online and offline healthcare platform in the People's Republic of China, with a market cap of $40.05 million.
Operations: The company generates revenue of CN¥14.66 billion from its operations in the People's Republic of China.
Market Cap: $40.05M
111, Inc. operates with a market cap of US$40.05 million and reported significant revenue generation of CN¥14.66 billion, indicating its active business operations in China. Despite being unprofitable, it has been reducing losses annually by 10.1% over the past five years and maintains a positive free cash flow with a cash runway exceeding three years. The company's stock is trading significantly below estimated fair value but experiences high volatility, recently executing a 1:10 stock split on January 24, 2025. Leadership changes include the appointment of Mr. Yang Luke Chen as director following Dr. Leon Lian Yong Chen's resignation.
-
Take a closer look at 111's potential here in our financial health report.
-
Assess 111's future earnings estimates with our detailed growth reports.
Butterfly Network
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions both in the United States and internationally with a market cap of approximately $837.33 million.